moxifloxacin
Showing 26 - 50 of 267
Healthy Subjects Trial in Toshima-ku (TS-142, Moxifloxacin, Placebo)
Completed
- Healthy Subjects
- TS-142
- +2 more
-
Toshima-ku, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022
Healthy Volunteers, Cardiac Repolarisation Trial in Leeds (LEO 152020, Moxifloxacin, Placebo)
Not yet recruiting
- Healthy Volunteers
- Cardiac Repolarisation
- LEO 152020
- +2 more
-
Leeds, United KingdomLEO Investigational Site
Aug 18, 2022
QT/QTc Trial in Austin (Ecopipam Hydrochloride, Moxifloxacin, Placebo)
Recruiting
- QT/QTc
- Ecopipam Hydrochloride
- +2 more
-
Austin, TexasPPD Austin Phase 1 Clinical Research Unit
Apr 21, 2023
Healthy Trial in Merksem (Aticaprant Supratherapeutic Dose, Aticaprant Therapeutic Dose, Placebo)
Completed
- Healthy
- Aticaprant Supratherapeutic Dose
- +3 more
-
Merksem, BelgiumClinical Pharmacology Unit
Nov 9, 2022
Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,
Not yet recruiting
- Tuberculosis, Pulmonary
- Other Specified Pulmonary Tuberculosis
- BTZ-043
- +3 more
-
Cape Town, South Africa
- +3 more
Jun 22, 2023
Restless Legs Syndrome Trial in Austin (GEn 1200mg, Gen 6000 mg, GEn Placebo)
Completed
- Restless Legs Syndrome
- GEn 1200mg
- +4 more
-
Austin, TexasGSK Investigational Site
Apr 7, 2021
Healthy Trial in Glendale (Setmelanotide, Moxifloxacin, Oral Placebo)
Completed
- Healthy
- Setmelanotide
- +3 more
-
Glendale, CaliforniaParexel Early Phase Clinical Unit (Los Angeles)
Jun 15, 2022
QTc Interval Trial in Overland Park (Psilocybin, Moxifloxacin, Micro-Crystalline Cellulose)
Recruiting
- QTc Interval
- Psilocybin
- +2 more
-
Overland Park, KansasAltasciences Clinical Kansas, Inc
Jul 26, 2022
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg
Recruiting
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +3 more
-
Johannesburg, South Africa
- +2 more
Oct 4, 2021
Phenylketonuria Trial in Fargo (sapropterin diHCl, Moxifloxacin, Moxifloxacin )
Completed
- Phenylketonuria
- sapropterin dihydrochloride
- +2 more
-
Fargo, North DakotaPRACS Institute, Ltd.
Jul 19, 2021
Diabetes Trial in London (Moxifloxacin, hyper-glycaemic clamp)
Completed
- Diabetes
- Moxifloxacin
- hyper-glycaemic clamp
-
London, United KingdomRichmond Pharmacology Ltd. 1a Newcomen St, London Bridge
Apr 29, 2021
Healthy Volunteers Trial in Miami (CTP-543, Moxifloxacin, Placebo)
Completed
- Healthy Volunteers
- CTP-543
- +2 more
-
Miami, FloridaClinical Pharmacology of Miami, LLC
Feb 16, 2022
CHF Trial in Fukuoka (OPC-61815 16mg, OPC-61815 32mg, Moxifloxacin)
Completed
- Congestive Heart Failure
- OPC-61815 16mg
- +3 more
-
Fukuoka, JapanKyusyu Region
Apr 13, 2021
Symptomatic Neurogenic Orthostatic Hypertension, nOH Trial in Tempe (Ampreloxetine <Dose A>, Ampreloxetine <Dose B>,
Completed
- Symptomatic Neurogenic Orthostatic Hypertension
- nOH
- Ampreloxetine <Dose A>
- +4 more
-
Tempe, ArizonaTheravance Biopharma Investigational Site
Apr 19, 2021
Tuberculosis Trial in Bandung (moxifloxacin)
Completed
- Tuberculosis
- moxifloxacin
-
Bandung, IndonesiaRumah Sakit Hasan Sadikin (RSHS)
Nov 9, 2020